Avalon/GSK Incubation Project Launches First Company, Focused On Celiac Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
New company Sitari will try to develop first drug therapy for celiac disease. Portfolio companies launched by GSK and Avalon also will have their own, dedicated CRO-like organization to handle much of their work.